|  |



Tecovirimat for Mpox: Does Immunocompromised, HIV Status Affect Clinical Outcomes?

Clinical outcomes of mpox were similar between patients with HIV infection and those without immunocompromised conditions who received ...


View article...


Top stories of the last 30 days